EXHIBIT 23.2








                             INDEPENDENT AUDITORS' CONSENT



To the Stockholders of
L.A.M. Pharmaceutical, Corp.
Toronto, Ontario, Canada


      We  consent  to  the  use  in  this   Registration   Statement  of  L.A.M.
Pharmaceutical,  Corp.  on  Form S-8  of  our  report  dated  February 27,  2003
(except  for  Note  O, as to  which  the  date  is  March 27,  2003)  of  L.A.M.
Pharmaceutical,  Corp.  for the years ended  December 31,  2002 and 2001, and to
the reference to us under the heading  "Experts" in the  Prospectus,  which is a
part of this Registration Statement.

      We also  consent to the use of our review  report dated May 6, 2003 on the
unaudited  interim  financial  information of L.A.M.  Pharmaceutical,  Corp. for
the three months ended March 31,  2003 and 2002, in this Registration  Statement
of L.A.M. Pharmaceutical, Corp. on Form S-8.

      We are also aware that the aforementioned report on the unaudited interim
financial information, pursuant to Rule 436(c) under the Securities Act of 1933,
is not considered a part of the Registration Statement prepared or certified by
an accountant or a report prepared or certified by an accountant within the
meaning of Sections 7 and 11 of that Act.




/s/ Rotenberg & Co., LLP

Rotenberg & Co., LLP
Rochester, New York

August 8, 2003